Touchstone
Last syncNov 1, 2026, 6:55 PM ET

ARDT

Ardent Health, Inc. Health Care Services-General Medical & Surgical Hospitals, NEC Russell 3000
$12.03Close $1.7BMarket cap $7.83 – $14.6852-week range Nov 4, 2026Next report · after the close

Highlights

Cautions

  • Trend not confirmed 7 of 8 conditions · RS under 70
  • Earnings shrinking EPS −77% year on year
  • Results soon Nov 4, 2026, in 3 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 10, 2026
Off 12-month high 18%
1wk down 2.0% price change
1mo up 16.3% price change
12-month return down 17% market up 11% · its own down 31%
F-score — — Not assessed
Altman Z″ 2.30 Moderate risk
P/E 12.7× price / earnings
PEG — P/E / EPS growth
P/B 1.3× price / book
Earnings yield up 13.7% EBIT / enterprise value
Cheaper than 94% of the market · markedly cheap
Revenue growth up 6% year on year
EPS growth down 77% latest quarter · -73 pts
Sales growth down 1% latest quarter · -8 pts
ROE up 11% return on equity
Free cash margin up 7% $470.5M FCF
D/E 0.84 long-term debt / equity
Net debt / EBITDA 0.8×
Interest cover —EBIT / interest

Trade setup

ATR% 3.4% $0.41 a day · 2×ATR $11.21
RS 69 / 99 vs the universe
Trend 7 / 8 RS under 70
Relative volume 0.9× vs 50-day average
Up/down volume 1.35 50 sessions
Implied move — no option chain · report Nov 4, 2026
Trend template · 7 of 8
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Aug 4, 2026
Results reaction Aug 4, 2026+2% vs market2 sessions after results

Financials

4 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $6.3B +6% on FY2024
$0 $10B FY22 FY23 FY24 FY25 FY2022 · $5.1B FY2023 · $5.4B FY2024 · $6.0B FY2025 · $6.3B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $135.8M -35% on FY2024
$0 $250M FY22 FY23 FY24 FY25 FY2022 · $188.9M FY2023 · $53.9M FY2024 · $210.3M FY2025 · $135.8M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $470.5M +49% on FY2024
$0 $500M FY22 FY23 FY24 FY25 FY2022 · -$38.4M FY2023 · $221.7M FY2024 · $315.0M FY2025 · $470.5M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 2%
  • Free cash 7%
0% 10% FY22 FY23 FY24 FY25 FY2022 · Net 4% · Free cash -1% FY2023 · Net 1% · Free cash 4% FY2024 · Net 4% · Free cash 5% FY2025 · Net 2% · Free cash 7%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $366.2M net debt
  • Cash
  • Long-term debt
$0 $2B FY22 FY23 FY24 FY25 FY2022 · Cash $456.1M FY2023 · Cash $437.6M · Long-term debt $1.2B FY2024 · Cash $556.8M · Long-term debt $1.1B FY2025 · Cash $709.6M · Long-term debt $1.1B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 142.86m
142.86m 0 FY22 FY23 FY24 FY25 FY2022 FY2023 · 0 FY2024 · 142.75m FY2025 · 142.86m
  FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $5.1B $5.4B $6.0B $6.3B
Net income $188.9M $53.9M $210.3M $135.8M
Net margin 4% 1% 4% 2%
Earnings per share $1.50 $0.43 $1.58 $0.96
Free cash flow -$38.4M $221.7M $315.0M $470.5M
Free cash margin -1% 4% 5% 7%
Cash $456.1M $437.6M $556.8M $709.6M
Long-term debt — $1.2B $1.1B $1.1B
Shareholders' equity $1.0B $670.9M $1.1B $1.3B
Shares outstanding — 0 142.75m 142.86m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 10, 2026 Quarterly ↗ Jun 30, 2026 41d
May 6, 2026 Quarterly ↗ Mar 31, 2026 36d
Mar 16, 2026 Annual ↗ Dec 31, 2025 75d
Nov 14, 2025 Quarterly ↗ Sep 30, 2025 45d
Aug 6, 2025 Quarterly ↗ Jun 30, 2025 37d
May 7, 2025 Quarterly ↗ Mar 31, 2025 37d
Feb 27, 2025 Annual ↗ Dec 31, 2024 58d
Nov 7, 2024 Quarterly ↗ Sep 30, 2024 38d
Aug 14, 2024 Quarterly ↗ Jun 30, 2024 45d

Current reports

FiledDisclosed
Oct 23, 2026 Director or officer change ↗
Sep 4, 2026 Other events ↗
Aug 4, 2026 Results ↗
Jun 30, 2026 Director or officer change ↗
Jun 2, 2026 Director or officer change · Regulation FD ↗
May 26, 2026 Shareholder vote ↗
May 5, 2026 Results ↗
Mar 27, 2026 Director or officer change ↗
Mar 4, 2026 Results ↗
Nov 18, 2025 Regulation FD · Other events ↗
Nov 12, 2025 Results ↗
Sep 23, 2025 Material agreement · New obligation ↗